Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study of PX-866 and Docetaxel in Solid Tumors [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study of PX-866 with docetaxel in solid tumors, including non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating azacitidine in combination with cisplatin in adults with advanced non-small cell lung cancer or squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: The Role of Chromoendoscopy in the Early Detection of Esophageal Cancer in Patients With Prior Head and Neck Cancers [NA]
This clinical trial update reports on a study evaluating chromoendoscopy for early detection of esophageal cancer in patients with prior hea…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment [Phase 1]
A Phase 1 safety study of the investigational drug MM-151 in patients with advanced solid tumors that have resisted standard treatment has c…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial [Phase 3]
A Phase 3 registration trial evaluating Taxotere (docetaxel) for squamous cell carcinoma of the head and neck has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: A Study Evaluating MM-310 in Patients With Solid Tumors [Phase 1]
This update reports a Phase 1 study evaluating MM-310 in patients with solid tumors. The listed indications include urothelial carcinoma, ga…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) [Phase 2]
Phase 2 trial evaluating intratumoral Hiltonol (poly-ICLC) for solid tumors was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of cetuximab and dasatinib in recurrent squamous cell carcinoma of the head and neck was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Phase II Study of RAD001 Head and Neck Cancer [Phase 2]
Phase II study of RAD001 in head and neck cancer was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update across multiple cancer types including ovarian, non-small cell lung, prostate, colorectal, gastric/esophageal,…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery [Phase 2]
Phase 2 clinical trial evaluating multimodality, risk-adapted treatment that includes induction chemotherapy for squamous cell carcinoma of …
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin [Phase 3]
Phase 3 trial comparing induction chemotherapy followed by cetuximab plus radiotherapy versus radiotherapy with cisplatin for head and neck …
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update for dalantercept in squamous cell carcinoma of the head and neck has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 study comparing two treatments in patients with recurrent or metastatic squamous cell carcinoma of the head and neck has completed…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
This post-marketing surveillance trial evaluating cetuximab plus radiotherapy in unresectable locally advanced head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract [Phase 2, Phase 3]
A completed Phase 2/3 trial comparing two re-irradiation protocols for squamous cell carcinoma of the head and neck in patients previously i…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck [Phase 2]
A Phase 2 clinical trial evaluating Bevacizumab/Tarceva and Tarceva/Sulindac in squamous cell carcinoma of the head and neck was terminated,…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: CTC Detection Rate in SCCHN With a in Vivo Device [NA]
The update describes a trial evaluating circulating tumor cell detection in squamous cell carcinoma of the head and neck using an in vivo de…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck [Phase 1]
A Phase 1 study evaluating the addition of panitumumab to chemoradiotherapy for squamous cell carcinoma of the head and neck has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1]
Phase 1 study evaluating azacitidine in combination with cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck;…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) [Phase 3]
Phase 3 trial comparing nivolumab to investigator's choice therapy in recurrent/metastatic squamous cell carcinoma of the head and neck comp…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck [Phase 1, Phase 2]
Phase 1/2 trial evaluating Abraxane with carboplatin, cetuximab (Erbitux) and IMRT for locally advanced squamous cell carcinoma of the head …
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study [Phase 2]
Phase 2 study of docetaxel/cisplatin/5-fluorouracil for HPV-positive head and neck squamous cell carcinoma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy
A post-marketing surveillance study of docetaxel-based chemotherapy in non-small cell lung cancer and head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck [Phase 2]
Phase 2 trial evaluating adjuvant cetuximab with chemoradiotherapy using either cisplatin or docetaxel in resected stage III/IV head and nec…